The board of directors of AbbVie Inc (NYSE:ABBV) declared on Thursday its quarterly dividend of USD1.30 per share of its stock.

This cash dividend is due on 16 August 2021 to stockholders of record at the close of business as of 15 July 2021.

Since the company's inception in 2013, it has increased its dividend by 225%.

According to the company, its mission is to discover and deliver medicines that solve serious health issues, address the medical challenges of tomorrow as well as focus on immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology.